{"hands_on_practices": [{"introduction": "The dissociation constant, $K_d$, is a cornerstone of pharmacology and biochemistry, providing a direct measure of a molecule's binding affinity. This exercise goes beyond the definition to show its practical utility: calculating the precise concentration of a ligand required to occupy a specific fraction of a target protein population. Mastering this relationship is essential for designing effective experiments and understanding dose-response relationships in drug development. [@problem_id:2142219]", "problem": "In a drug discovery project, a research team is studying the binding of a small molecule inhibitor to its target protein. The equilibrium dissociation constant, $K_d$, for the binding of the inhibitor to the protein has been experimentally determined to be $100$ nM. For the inhibitor to be effective, a specific fraction of the target protein molecules must be bound by it. Assuming the system is at equilibrium, calculate the concentration of free inhibitor that is required to ensure that exactly $75\\%$ of the total protein molecules are in a bound state.\n\nExpress your final answer in units of nanomolar (nM).", "solution": "Let $[P]$ denote free protein, $[L]$ free inhibitor, and $[PL]$ the complex. For $P + L \\rightleftharpoons PL$, the equilibrium dissociation constant is defined by\n$$\nK_{d}=\\frac{[P][L]}{[PL]}.\n$$\nThe total protein concentration is $[P]_{T}=[P]+[PL]$, and the bound fraction is\n$$\nf=\\frac{[PL]}{[P]_{T}}.\n$$\nFrom the definition of $K_{d}$, express $[PL]$ in terms of $[P]$ and $[L]$:\n$$\n[PL]=\\frac{[P][L]}{K_{d}}.\n$$\nUse $[P]=[P]_{T}-[PL]$ to eliminate $[P]$:\n$$\n[PL]=\\frac{([P]_{T}-[PL])[L]}{K_{d}}.\n$$\nRearrange to isolate $[PL]$:\n$$\n[PL]\\left(1+\\frac{[L]}{K_{d}}\\right)=\\frac{[P]_{T}[L]}{K_{d}}\n\\quad\\Rightarrow\\quad\n[PL]=\\frac{[P]_{T}[L]}{K_{d}+[L]}.\n$$\nThus the bound fraction is\n$$\nf=\\frac{[PL]}{[P]_{T}}=\\frac{[L]}{K_{d}+[L]}.\n$$\nSolve this for $[L]$ at a desired bound fraction $f$:\n$$\nf(K_{d}+[L])=[L]\n\\;\\Rightarrow\\;\nfK_{d}= [L](1-f)\n\\;\\Rightarrow\\;\n[L]=\\frac{f}{1-f}\\,K_{d}.\n$$\nFor $f=\\frac{3}{4}$,\n$$\n[L]=\\frac{\\frac{3}{4}}{1-\\frac{3}{4}}\\,K_{d}=3K_{d}.\n$$\nWith $K_{d}=100\\ \\text{nM}$, the required free inhibitor concentration is $[L]=3\\times 100\\ \\text{nM}=300\\ \\text{nM}$. As requested, we report only the numerical value in nanomolar.", "answer": "$$\\boxed{300}$$", "id": "2142219"}, {"introduction": "While $K_d$ quantifies the strength of a molecular interaction, it is fundamentally governed by thermodynamics. This practice bridges the gap between the equilibrium constant of binding and the standard Gibbs free energy change, $\\Delta G^\\circ$, revealing the spontaneity and energetic favorability of the process. By converting an experimentally measured $K_d$ into a $\\Delta G^\\circ$ value, we gain deeper insight into the driving forces behind molecular recognition. [@problem_id:2142196]", "problem": "A team of biochemists is investigating a newly engineered therapeutic protein designed to bind to a specific cell surface receptor implicated in a disease pathway. Using surface plasmon resonance (SPR), they have precisely measured the kinetics of the binding interaction under physiological conditions. The dissociation constant ($K_d$) for the protein-receptor complex was determined to be 7.50 nanomolar (nM). The binding experiment was conducted at a standard human body temperature of 37.0 degrees Celsius.\n\nGiven the ideal gas constant $R = 8.314 \\, \\text{J}\\cdot\\text{mol}^{-1}\\cdot\\text{K}^{-1}$, calculate the standard Gibbs free energy of binding ($\\Delta G^\\circ$) for this interaction. Express your answer in kilojoules per mole (kJ/mol), rounded to three significant figures.", "solution": "The goal is to calculate the standard Gibbs free energy of binding ($\\Delta G^\\circ$) from the given dissociation constant ($K_d$) and temperature ($T$).\n\nThe relationship between the standard Gibbs free energy change and the equilibrium constant ($K_{eq}$) of a reaction is given by the equation:\n$$\n\\Delta G^\\circ = -RT \\ln(K_{eq})\n$$\nwhere $R$ is the ideal gas constant and $T$ is the absolute temperature in Kelvin.\n\nFor a protein-ligand binding reaction, the equilibrium constant is typically represented as the association constant ($K_a$). The reaction can be written as:\n$$\n\\text{Protein} + \\text{Receptor} \\rightleftharpoons \\text{Protein-Receptor Complex}\n$$\nThe association constant is defined as:\n$$\nK_a = \\frac{[\\text{Protein-Receptor Complex}]}{[\\text{Protein}][\\text{Receptor}]}\n$$\nThe dissociation constant ($K_d$) is the reciprocal of the association constant ($K_a$):\n$$\nK_d = \\frac{1}{K_a}\n$$\nTherefore, we can express the standard Gibbs free energy in terms of the dissociation constant $K_d$. Substituting $K_{eq} = K_a = 1/K_d$ into the Gibbs free energy equation:\n$$\n\\Delta G^\\circ = -RT \\ln\\left(\\frac{1}{K_d}\\right)\n$$\nUsing the logarithmic identity $\\ln(1/x) = -\\ln(x)$, the equation becomes:\n$$\n\\Delta G^\\circ = RT \\ln(K_d)\n$$\nBefore we can calculate $\\Delta G^\\circ$, we must convert the given values into SI units to be consistent with the units of the gas constant $R$.\n\nFirst, convert the temperature from degrees Celsius to Kelvin:\n$$\nT(\\text{K}) = T(^\\circ\\text{C}) + 273.15\n$$\n$$\nT = 37.0 + 273.15 = 310.15 \\, \\text{K}\n$$\n\nNext, convert the dissociation constant $K_d$ from nanomolar (nM) to molar (M). Since $1 \\, \\text{nM} = 10^{-9} \\, \\text{M}$:\n$$\nK_d = 7.50 \\, \\text{nM} = 7.50 \\times 10^{-9} \\, \\text{M}\n$$\nNote that for the calculation within the logarithm, $K_d$ should be treated as a dimensionless quantity representing the concentration in M relative to the standard state of 1 M.\n\nNow, we can substitute the values into the equation for $\\Delta G^\\circ$:\n$$\n\\Delta G^\\circ = (8.314 \\, \\text{J}\\cdot\\text{mol}^{-1}\\cdot\\text{K}^{-1}) \\times (310.15 \\, \\text{K}) \\times \\ln(7.50 \\times 10^{-9})\n$$\nFirst, calculate the natural logarithm:\n$$\n\\ln(7.50 \\times 10^{-9}) \\approx -18.708\n$$\nNow, multiply by $R$ and $T$:\n$$\n\\Delta G^\\circ \\approx (8.314 \\, \\text{J}\\cdot\\text{mol}^{-1}\\cdot\\text{K}^{-1}) \\times (310.15 \\, \\text{K}) \\times (-18.708)\n$$\n$$\n\\Delta G^\\circ \\approx 2578.5 \\, \\text{J}\\cdot\\text{mol}^{-1} \\times (-18.708)\n$$\n$$\n\\Delta G^\\circ \\approx -48238 \\, \\text{J}\\cdot\\text{mol}^{-1}\n$$\nThe problem asks for the answer in kilojoules per mole (kJ/mol). To convert from joules to kilojoules, we divide by 1000:\n$$\n\\Delta G^\\circ \\approx -48.238 \\, \\text{kJ}\\cdot\\text{mol}^{-1}\n$$\nFinally, we round the answer to three significant figures as requested:\n$$\n\\Delta G^\\circ = -48.2 \\, \\text{kJ}\\cdot\\text{mol}^{-1}\n$$", "answer": "$$\\boxed{-48.2}$$", "id": "2142196"}, {"introduction": "In real-world drug discovery, it is not always feasible to directly label the compound of interest to measure its binding affinity. This hands-on problem simulates a common and powerful alternative: the competitive binding assay. You will learn how to use the experimentally determined $IC_{50}$ value—the concentration of an unlabeled inhibitor required to displace 50% of a labeled probe—to calculate the true inhibition constant, $K_i$, using the indispensable Cheng-Prusoff equation. [@problem_id:2142220]", "problem": "A research team is developing a new inhibitor, named Drug-X, for a protein kinase known as Kinase Associated with Proliferation (KAP). To quantify the binding affinity of this unlabeled compound, they perform a competitive binding assay using Fluorescence Polarization (FP).\n\nThe experiment is set up as follows: a fixed concentration of a fluorescently-labeled probe ligand is incubated with a fixed concentration of the KAP protein. This probe is known to bind to the active site of KAP with a dissociation constant ($K_d$) of 12.0 nM. The total concentration of this fluorescent probe in the assay is maintained at 4.00 nM.\n\nVarying concentrations of the unlabeled Drug-X are then added to this mixture. The FP signal, which is proportional to the fraction of the fluorescent probe bound to the protein, is measured for each concentration of Drug-X. The data reveal that the concentration of Drug-X required to reduce the specific binding of the fluorescent probe by 50% is 88.0 nM.\n\nAssuming that Drug-X acts as a direct competitive inhibitor, binding to the same site as the fluorescent probe, calculate the inhibition constant ($K_i$) for Drug-X.\n\nExpress your final answer in nM, rounded to three significant figures.", "solution": "We consider equilibrium competitive binding between a labeled ligand $L$ and an unlabeled inhibitor $I$ for a single site on protein $P$. The labeled ligand binds with dissociation constant $K_{d}$, and the inhibitor has inhibition constant $K_{i}$. In a competitive assay at fixed $[L]$, the concentration of inhibitor that reduces the specific binding of $L$ by one-half is $IC_{50}$. For direct competition at equilibrium, the Cheng–Prusoff relationship holds:\n$$\nK_{i}=\\frac{IC_{50}}{1+\\frac{[L]}{K_{d}}}.\n$$\n\nHere, the fluorescent probe has $K_{d}=12.0\\ \\text{nM}$ and total concentration $[L]=4.00\\ \\text{nM}$, and the measured $IC_{50}$ for Drug-X is $88.0\\ \\text{nM}$. Substituting,\n$$\nK_{i}=\\frac{88.0}{1+\\frac{4.00}{12.0}}\\ \\text{nM}.\n$$\nCompute the denominator:\n$$\n1+\\frac{4.00}{12.0}=1+\\frac{1}{3}=\\frac{4}{3}.\n$$\nThus,\n$$\nK_{i}=88.0\\times\\frac{3}{4}=66.0\\ \\text{nM}.\n$$\nRounded to three significant figures, $K_{i}=66.0\\ \\text{nM}$.", "answer": "$$\\boxed{66.0}$$", "id": "2142220"}]}